Novus Announces Two Contest Winners

Littleton, CO, October 14, 2011 --(PR.com)-- Novus Biologicals announced today the winners of two customer contests.

First, the third quarter Novus Travel Grant winner is Dr. Toryn Poolman of the University of Manchester's School of Medicine, selected for his excellent review of our Glucocorticoid Receptor Antibody (NB300-610). Dr. Poolman will receive a $500 travel grant covering airfare and conference registration. Submit your review online or contact rewards@novusbio.com for your chance to win next quarter.

Second, Novus Europe’s iPad2 drawing winner is Dr. Ansgar Brüning of the University Hospital Munich. Dr. Brüning met Novus at the EMBO conference last month and was randomly selected from all contacts they met at their various European conferences in September. Congratulations to both winners!

About Novus Biologicals (www.novusbio.com)

Novus Biologicals is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies, proteins, peptides, isotype and loading controls, RNAi, lysates, stem cell lines and antibody labeling kits to the bioscience community. All of Novus' products are 100% guaranteed to work in the species and applications listed on the datasheet. By serving niche and emerging markets, Novus Biologicals has formed and will continue to form ongoing partnerships with leading researchers.

###